| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4272619 | The Journal of Sexual Medicine | 2008 | 7 Pages |
Abstract
Although further studies are necessary before definitive conclusions can be drawn, the available evidence suggests that TRT can be cautiously considered in selected hypogonadal men treated with curative intent for PCa and without evidence of active disease. Rhoden EL, Averbeck MA, and Teloken PE. Androgen replacement in men undergoing treatment for prostate cancer. J Sex Med 2008;5:2202-2208.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Ernani Luis MD, PhD, Márcio Augusto MD, Patrick E. Teloken,